CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities:
Net loss	$ (2,544)	$ (3,305)
Depreciation and amortization	411	279
Stock-based compensation expense	364	559
Inventory write-downs and losses on firm purchase commitments	220	301
Other non-cash activities	7	63
Changes in operating assets and liabilities:
Accounts receivable, net	(239)	(37)
Inventory	(1,190)	(620)
Other current assets	(44)	18
Other non-current assets	(38)	(19)
Accounts payable and accrued liabilities	16	421
Other current liabilities	53	70
Other non-current liabilities	102	32
Net cash used in operating activities	(2,882)	(2,238)
Cash flows from investing activities:
Purchase of short-term investments	(938)	0
Capital expenditures	(538)	(777)
Net cash used in investing activities	(1,476)	(777)
Cash flows from financing activities:
Proceeds from issuance of capital stock including employee stock purchase plan	37	58
Proceeds from issuance of convertible notes	1,485	0
Other financing activities	(5)	(2)
Net cash provided by financing activities	1,517	56
Effect of exchange rate changes on cash and cash equivalents	2	(1)
Net change in cash	(2,839)	(2,960)
Cash, cash equivalents, and restricted cash—Beginning of period	12,099	18,423
Cash, cash equivalents, and restricted cash—End of period	9,260	15,463
Supplemental disclosure of non-cash investing and financing activities:
Capital expenditures included in liabilities	338	358
Capital stock issued to settle bonuses	137	0
Right-of-use assets obtained in exchange for operating lease liabilities	$ 27	$ 84